Press Area
Dr.Guido Intro (short)
Dr. Guido: Your AI-based Doctor for empathetic interactions. Pre-diagnosis, second opinions, and more via our mobile app. Privacy and AIAct compliance assured.
Dr.Guido Intro (long)
Official Presentations
Official Presentations
Ufficial Images
Press Releases
Lisbon, November 2024 – DrGuido.ai, the startup revolutionizing digital healthcare, will participate in WebSummit 2024 with a major announcement. During the event, DrGuido.ai will officially introduce its AI-powered mobile app, designed to offer consumers an empathetic and secure interaction with an "AI Doctor." The app supports patients in managing their health by providing pre-diagnoses, second opinions, and information about prescribed medications.
DrGuido.ai’s core innovation lies in combining artificial intelligence with a humanized approach, ensuring interactions go beyond simple medical information exchange. Through an intuitive graphical configurator, users can engage with the AI Doctor and share the pre-diagnosis results with their primary care physician. The app also allows users to purchase over-the-counter drugs and supplements directly from certified online pharmacies and connect with specialists to schedule appointments.
A Secure and AIAct-Compliant Digital Healthcare Solution
Patient privacy and security are top priorities for DrGuido.ai, which operates in full compliance with European regulations, particularly the AIAct, which governs the use of artificial intelligence. All information is handled with the utmost confidentiality, offering users a reliable and transparent healthcare experience.
Expansion and Fundraising Plan
At WebSummit 2024, DrGuido.ai will also present its ambitious expansion and fundraising plan. The startup is seeking strategic partners and investors to accelerate its growth and develop additional features, such as integration with wearable devices and advanced telemedicine solutions.
“We are excited to participate in WebSummit and share our vision of making healthcare more accessible, empathetic, and driven by cutting-edge technologies,” said the CEO of DrGuido.ai. “Our goal is to provide people with innovative tools to manage their health in an informed and secure way.”
Milan, September 2024 – DrGuido.ai is not an alternative to traditional medicine but a powerful support tool for the healthcare sector. The application, and specifically the integrated AI chatbot – the "AI Doctor" – is designed to provide a pre-diagnosis of the symptoms presented by users/patients, helping them better understand their conditions and offering initial suggestions to alleviate any discomfort.
An Empathetic Approach to Pre-Diagnosis
DrGuido's AI chatbot has been carefully trained to create an empathetic interaction with users. During the conversation, the chatbot asks targeted questions until it forms a preliminary idea of the possible issue. At the end of the session, the pre-diagnosis always comes with a clear invitation to consult a specialist for an accurate, final diagnosis. Additionally, the chatbot offers suggestions for home remedies or over-the-counter medications to relieve pain, where appropriate, while waiting for the medical appointment.
A Bridge Between Patients and Doctors
DrGuido.ai does not replace the relationship between patient and doctor but strengthens it. At the end of each conversation with the AI Doctor, the app allows users to send a detailed report of the discussion to their primary care physician. This tool provides doctors with a preliminary overview of the patient's symptoms before the consultation. Furthermore, the app helps users identify suggested local specialists, providing contact information and facilitating appointment bookings.
An Ally for the Healthcare Sector
DrGuido.ai's goal is to support doctors, not to compete with them. By providing an initial analysis and preliminary advice, the app helps reduce the workload of healthcare professionals, allowing them to focus on more complex and urgent cases. DrGuido.ai also contributes to improving access to care, especially in areas where medical specialists may be difficult to reach. Through its technology, the app facilitates more efficient communication between patients and doctors, enhancing the quality of healthcare.
"We strongly believe that technology can be a valuable ally for healthcare professionals," said the CEO of DrGuido.ai. "Our app is not intended to replace medical judgment but to provide preliminary support that helps patients manage their symptoms better and prepare for a specialist consultation."
A Digital Support at the Service of Doctors
DrGuido.ai is committed to collaborating with the healthcare sector to add value by improving efficiency and access to medical care. AI technology is not a competitor but a support tool that can help doctors respond more effectively to their patients' needs.
Milan, September 2024 – DrGuido.ai was born with the goal of making generative artificial intelligence accessible to everyone, not just professionals or the workforce. The DrGuido.ai mobile app offers an intuitive graphical interface that guides users in creating a personalized prompt for starting a conversation with the AI chatbot, enabling direct and precise interaction on specific medical issues.
The app allows users to configure their prompt in various ways: defining symptoms for which they seek a pre-diagnosis, uploading PDF documents for in-depth analysis or diagnosis, or photographing a medication package to receive detailed information on its composition, indications, contraindications, and usage instructions. Once the prompt is configured, the app initiates the conversation with the AI chatbot, which is available in over 50 languages, ensuring that users receive precise and contextually relevant responses in their preferred language.
Distinction Between Language Support and User Interface
A key feature of DrGuido.ai is its ability to engage in conversations with users in all major languages worldwide. The chatbot supports more than 50 languages, allowing users to conduct medical discussions in the language they are most comfortable with, regardless of geographic location. However, the app’s navigation interface and page information are currently available in three main languages: Italian, English, and French. This ensures a user-friendly and intuitive experience for the majority of global users.
Innovation and Accessibility in Health Management
DrGuido.ai represents a new way of interacting with artificial intelligence in healthcare. The flexibility to configure prompts based on symptoms or uploaded medical documents allows users to obtain personalized and timely responses. They can easily access pre-diagnoses, medical opinions, or drug information in real-time, thanks to an interface designed to provide clear and immediate dialogue.
A Vision for the Future of Digital Healthcare
DrGuido.ai stands at the forefront of innovation in the healthcare sector, offering practical solutions to improve access to medical information, both for everyday users and for those living in regions with limited access to healthcare services. With the support of an intuitive, multilingual interface, DrGuido.ai makes artificial intelligence a useful and accessible ally for everyday health.
Milano, September 2024 – DrGuido.ai is far more than just a business investment. It is an initiative with a powerful social impact, aimed at improving access to healthcare in regions of the world where infrastructure is lacking or difficult to reach. Through its innovative platform, DrGuido.ai offers vital first-line medical support to people living in areas where it is challenging to find a doctor or access essential medical services.
A Technological Solution to Bridge Global Healthcare Gaps
DrGuido.ai was created with the vision of making healthcare more accessible through artificial intelligence. The platform allows patients to receive pre-diagnoses, request second opinions, and obtain information about medications, providing immediate and timely assistance to those who might otherwise lack access to medical care. In many parts of the world, particularly in rural or underserved communities, healthcare resources are scarce. Here, DrGuido.ai acts as a reliable gateway to medical assistance, helping low-income populations gain access to healthcare support that can make a critical difference.
International Interest and Strategic Collaborations
DrGuido.ai is attracting significant attention from regions such as South America, South Africa, and Asia. In these areas, where the shortage of medical professionals is particularly severe, local governments and healthcare organizations see the app as a practical solution to bridge the gap left by inadequate healthcare infrastructure. DrGuido.ai not only provides virtual medical assistance to those most in need but also helps reduce the burden on local healthcare professionals, allowing them to focus on more severe and urgent cases.
Strategic partnerships with public and private entities are playing a crucial role in the expansion of DrGuido.ai. Through collaborations with non-governmental organizations, pharmaceutical companies, and local governments, DrGuido.ai aims to deliver comprehensive and targeted healthcare support. The platform offers patients not only medical information but also the ability to connect with specialists, book medical appointments, and access over-the-counter medications and supplements through certified online pharmacies.
An Investment Combining Profit and Social Impact
For investors, DrGuido.ai presents a unique opportunity. It is not just about supporting an innovative technological platform; it is about actively contributing to global healthcare equity. In a world where inequalities in access to medical care are increasingly apparent, DrGuido.ai offers a tangible solution to improving the quality of life in underserved communities.
“We are proud to be making a difference in regions where people are in desperate need of access to healthcare,” said the CEO of DrGuido.ai. “Our goal is to bring basic healthcare to those who need it most, wherever they are, leveraging the power of artificial intelligence.”
Investing in DrGuido.ai means making a conscious choice that combines the potential for economic growth with long-term social impact. With a scalable model adaptable to various local realities, DrGuido.ai has the potential to become a strategic partner in improving global healthcare conditions.
Dr.Guido, the pioneering startup in the field of digital health, is spearheading a revolution in the global healthcare sector with its innovative AI-driven platform. The significance of Dr.Guido lies in its mission to make healthcare accessible to all, including countries with a scarcity of doctors, revolutionizing how people interact with medical care.
Dr.Guido's distinctive approach focuses on empathy between patients and the AI Doctor, redefining the concept of personalized and accessible healthcare. Unlike competing with doctors, Dr.Guido provides an AI-driven pre-diagnosis, which patients can share with physicians to expedite the understanding of medical conditions.
It is important to emphasize that, despite its ability to offer a preliminary assessment, Dr.Guido always advises patients to consult a specialist for an accurate diagnosis and appropriate treatment.
Dr.Guido's mobile app offers a range of innovative services, including Second Opinion and SmartScan Med. These tools allow patients to obtain a second opinion on diagnoses and treatments, as well as detailed information on medications through a simple scan.
Currently operational in Milan, Dr.Guido is now raising funds for an aggressive international expansion strategy. In the meantime, the website offers users the opportunity to test the empathic interaction with the AI Doctor without the need for registration.
Milan, Italy - February 16, 2023 - DrGuido.ai, the innovative AI-driven healthcare startup, concluded its first public presentation at the AI*Festival in Milan on February 15th. The two-day event witnessed overwhelming interest and curiosity from the audience regarding the AI Doctor mobile app. With over 250 inquiries and 150 AI Doctor tests conducted on the website www.drguido.ai, the response was beyond expectations.
Most attendees were drawn to the first B2C application of generative artificial intelligence. Many questions revolved around privacy and how the medical sector would perceive this type of innovation. In summary, the event gathered many confirmations of the strategic key points presented by the mobile app: 1) native Zero Party Data in terms of privacy, 2) central focus on empathy rather than medical knowledge, 3) not a healthcare support but a tool for engaging with consumers on healthcare topics, 4) tool for summarizing requests to forward to healthcare professionals, where DrGuido offers the option to send a summary to the primary care physician at the end of the user interaction, 5) focus on Pre-Diagnosis results rather than diagnosis, with Pre-Diagnosis representing a hypothesis of identified problems based on provided information, 6) in every Pre-Diagnosis, DrGuido always suggests contacting a doctor or specialist for a diagnosis and potential prescription of medication or treatment, 7) proposed price of the premium version €4.97, accessible and excellent for services offered, such as SecondOpinion, which, by uploading a document like an analysis or diagnosis, produces a detailed description always with an empathetic tone towards the individual user. SmartScan, which, with a photo of a medication, provides a comprehensive and empathetic description of the medication, indicating its purpose, how to use it, and any contraindications.
In conclusion, DrGuido is not a medical or telemedicine support but an empathetic response tool to user questions. The event audience strongly affirmed that DrGuido represents an initial demonstration of how Generative Artificial Intelligence can be a tool that will benefit people of all ages, rather than posing a danger to humanity. There were also many proposals for collaboration and partnerships, including potential investors interested in DrGuido as a tool for countries in the developing world, where access to medical services is almost nonexistent. In short, all the conditions are in place for a great success and a case of a highly successful startup at the international level.
DrGuido, the revolutionary startup in AI-based healthcare, is pleased to announce its participation in the highly anticipated World AI Cannes Festival (WAICF), scheduled from February 8th to February 10th, 2024, in Cannes.
WAICF is one of the most prestigious international events dedicated to AI, bringing together experts, innovators, and industry leaders to explore the challenges and opportunities of artificial intelligence. This event provides an ideal platform for DrGuido to showcase the progress of its innovative AI Doctor App in the field of healthcare.
The DrGuido team will be available to discuss potential collaboration, partnerships, and investment opportunities with companies and professionals interested in transforming healthcare through technology.
We look forward to meeting you at the AI Conference in Cannes on 02/08/2024 and sharing DrGuido's vision for a more accessible and empathetic future in healthcare.
For more information or to schedule a meeting, please contact us
The mission of DrGuido.ai is to transform the digital health sector through the pioneering use of generative artificial intelligence. Our AI-driven mobile app focuses on providing pre-diagnosis services, offering users quick and personalized access to health evaluations based on advanced data. "We aim to be leaders in the use of generative AI for digital health, offering a B2C solution that is already redefining the way people access medical care" says Gabriele Taviani, Founder and Business Advisor of DrGuido.ai.
One of the main driving forces of DrGuido.ai is the commitment to protecting users' personal data. The startup operates in full compliance with recent privacy regulations, including careful adherence to the European Community's AiAct. This approach ensures not only technological excellence but also maximum security and respect for user privacy.
In addition, DrGuido.ai stands out for its unique organizational structure, with a board composed of young university students and recent graduates, who bring freshness, innovation, and a cutting-edge perspective. This choice reflects the startup's commitment to promoting new talents and revolutionary ideas in the field of healthcare technology.
The Ai*Festival event will be an unmissable opportunity to get a close look at DrGuido.ai and its innovations in the field of digital health. We invite investors, industry experts, and media to join us in discovering the future of AI-assisted pre-diagnosis and to seize the opportunity to invest in one of the most promising startups in the field of generative artificial intelligence.